Gemäss einer Schätzung der Schweizerischen Vereinigung Psychiatrischer Chefärztinnen und Chefärzte (SVPC) und niedergelassener Psychiater:innen läuft die Schweiz Gefahr, ab etwa dem Jahr 2030 substantiell zu wenig in der Praxis niedergelassene Psychiater:innen zu haben. Dies steht im Gegensatz zu internationalen Trends, die ein zunehmendes Interesse von Kandidat:innen am Fach Psychiatrie und Psychotherapie verzeichnen.
The presented article summarizes the topics and recommendations of a large-scale mixed-methods study on behalf of the Swiss Federal Office of Justice. The mandate was to evaluate the implementation of involuntary admission (Fürsorgerische Unterbringung, FU) and coercion as well as measures to promote patients’ autonomy in Switzerland to assess a possible need for revision of the legal articles on the regulation of coercion.
Strokes following a suicide attempt are rare and seem to affect younger patients presenting with more severe strokes and higher medium-term mortality. While carotid dissection emerged as the predominant cause, several other stroke mechanisms have been identified.
Data was collected between July and the end of November 2021 via an online questionnaire among mental health professionals in Europe. The Swiss data was collected via the same online questionnaire, which was widely distributed at a local level thanks to the efforts of professional associations, psychiatric institutions and health schools. The questionnaire was divided into three sections: organizational adaptations, use of digital tools, and professional and personal experience of the health crisis.
Short, accurate, rapidly completed psychometric tests are in high demand in psychiatry. Time is always limited. Researchers often try not to overburden patients included in studies measuring many variables. However, shorter psychometric tests may demonstrate poorer reliability or lower sensitivity. Computerised adaptive testing (CAT) could be a solution to this important trade-off.
In the Swiss pharmaceutical market, supply shortages for individual medicines are becoming increasingly frequent. In 2021, this affected Sevre-Long®, a drug used for many patients under opioid agonist therapy (OAT). Due to the exhaustion of local stock quantities at Lucerne Psychiatry, the affected patients had to be switched to the only other approved morphine preparation effective over 24 hours (Kapanol®) in spring 2022. We retrospectively investigated the type and frequency of complications as well as subjectively described problems of under- or overdose in the period of four weeks after this forced switch of the opioid agonist.
